Trials / Completed
CompletedNCT04147962
Intense Pulsed Light in Meibomian Gland Dysfunctions
Intense Pulsed Light in Meibomian Gland Dysfunctions: Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Dry eye disease (DED) is an extremely common disease whose meibomian gland dysfunction is the main etiology. Polychromatic intense pulsed light (IPL) is a promising new therapeutic alternative but few clinical data have been published. A new IPL device has recently been marketed: LACRYSTIM (QUANTEL, France). The investigators have been using it in our clinical practice since June 2019. The investigators present a retrospective study on our first clinical results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | intense pulsed light (usual practice) | collection data : parameters used for each treatment session: duration of treatment session and intensity of intense pulsed light |
Timeline
- Start date
- 2019-10-25
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
- First posted
- 2019-11-01
- Last updated
- 2022-05-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04147962. Inclusion in this directory is not an endorsement.